Literature DB >> 1849770

Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes.

H Glossmann1, C Zech, J Striessnig, R Staudinger, L Hall, R Greenberg, B I Armah.   

Abstract

1. Piperazinylindoles (DPI 201-106, BDF 8784), drugs known to act on voltage-dependent Na(+)-channels, bind with very high affinity to a Ca2(+)-channel-associated phenylalkylamine receptor in Drosophila melanogaster head membranes. These compounds and (+)-tetrandrine, a naturally occurring Ca2(+)-antagonist, were the most selective inhibitors for phenylalkylamine-labelled Drosophila Ca2(+)-channels compared to mammalian L-type Ca2(+)-channels. 2. Replacement of the cyano group by a methyl group in (+)-DPI 201-106 ((+)-BDF 8784) increases the IC50 value for inhibition of phenylalkylamine labelling of Drosophila Ca2(+)-channels from 0.29 to 2.1 nM but decreases the IC50 value for inhibition of phenylalkylamine labelling of mammalian skeletal muscle Ca2(+)-channels from 3480 to 49 nM. 3. DPI 201-106 enantiomers completely block (at 0.1 microM) phenylalkylamine photolabelling of a 136 K polypeptide in Drosophila head membranes whereas 10 microM aconitine or lidocaine are without effect. 4. Assessment of the Ca2(+)-antagonist effects of the substituted DPI 201-106 enantiomers in K(+)-depolarized taenia strips from guinea-pig caecum yielded pA2 values of 6.33 +/- 0.07 for (-)-BDF 8784 and 6.99 +/- 0.17 for (+)-BDF 8784, respectively. 5. Piperazinylindoles, previously believed to act nonspecifically on voltage-dependent mammalian L-type Ca2(+)-channels, therefore have stereoselectivity for a novel binding site and chemical selectivity unrelated to local anaesthetic activity. 6. It is proposed that a very high affinity piperazinylindole-selective site is coupled to the phenylalkylamine receptor of Drosophila Ca2(+)-channels. These sites are still present on mammalian L-type Ca2(+)-channels but have lower affinity and/or are less tightly coupled to phenylalkylamine receptors on the alpha 1-subunit.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1849770      PMCID: PMC1918021          DOI: 10.1111/j.1476-5381.1991.tb12193.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

Review 1.  Molecular properties of calcium channels.

Authors:  H Glossmann; J Striessnig
Journal:  Rev Physiol Biochem Pharmacol       Date:  1990       Impact factor: 5.545

Review 2.  Calcium channels: molecular pharmacology, structure and regulation.

Authors:  M M Hosey; M Lazdunski
Journal:  J Membr Biol       Date:  1988-09       Impact factor: 1.843

3.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

4.  Interaction between DPI 201-106 enantiomers at the cardiac sodium channel.

Authors:  G Wang; M Dugas; I Ben Armah; P Honerjäger
Journal:  Mol Pharmacol       Date:  1990-01       Impact factor: 4.436

5.  Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action.

Authors:  H G Knaus; F Scheffauer; C Romanin; H G Schindler; H Glossmann
Journal:  J Biol Chem       Date:  1990-07-05       Impact factor: 5.157

6.  [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain.

Authors:  A Grassegger; J Striessnig; M Weiler; H G Knaus; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.

Authors:  A Schmid; G Romey; J Barhanin; M Lazdunski
Journal:  Mol Pharmacol       Date:  1989-06       Impact factor: 4.436

8.  Assessment of "Ca2+ -antagonist" effects of drugs in K+ -depolarized smooth muscle. Differentiation of antagonist subgroups.

Authors:  M Spedding
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle.

Authors:  A Goll; D R Ferry; J Striessnig; M Schober; H Glossmann
Journal:  FEBS Lett       Date:  1984-10-29       Impact factor: 4.124

View more
  1 in total

1.  Investigations of the dual contractile/relaxant properties showed by antioquine in rat aorta.

Authors:  M D Ivorra; C Lugnier; M Catret; E Anselmi; D Cortes; P D'Ocon
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.